Skip to main content

Table 3 Correlation of clinicopathologic parameters with breast cancer subtypes

From: Breast cancer in togolese women: immunohistochemistry subtypes

Variables

Luminal A

N = 36

n (%)

Luminal B

N = 28

n (%)

Triple negative

N = 44

n (%)

HER enriched

N = 9

n (%)

P value

Mean age (years)

54.14 ± 12.7

51.07 ± 13.19

52.16 ± 12.44

46.33 ± 6.30

0.377

Age group (years)

     

 < 40

1 (2.8)

5 (17.9)

8 (18.1)

1 (11.1)

0.172

[40–50]

14 (38.9)

6 (21.4)

12 (27.3)

6 (66.7)

 

[50–60]

12 (33.3)

10 (35.7)

12 (27.3)

2 (22.2)

 

 ≥ 60

9 (25)

7 (25)

12 (27.3)

0

 

Menopausal status

     

Premenopausal

7 (19.4)

10 (35.7)

13 (29.5)

5 (44.4)

0.163

Postmenopausal

29 (80.6)

18 (64.3)

31 (70.5)

4 (55.6)

 

Stage

     

I

3 (8.3)

0

0

0

0.025

II

15 (41.7)

12 (42.9)

18 (40.9)

0

 

III

15 (41.7)

7 (25)

15 (34.1)

5 (55.6)

 

IV

3 (8.3)

9 (32.1)

11 (25)

4 (44.4)

 

Grade

     

1

4 (11.1)

0

3 (6.8)

0

 < 0.0001

2

29 (80.6)

7 (25)

17 (38.6)

7 (77.8)

 

3

3 (8.3)

21 (75)

24 (54.6)

2 (22.2)

 

Tumor size

     

T1

6 (16.7)

1 (3.6)

3 (6.8)

0

0.078

T2

16 (44.4)

13 (46.4)

17 (38.7)

0

 

T3

9 (25)

7 (25)

10 (22.7)

0

 

T4

5 (13.9)

7 (25)

14 (31.8)

9 (100)